Factors influencing physician decisions to discontinue treatment after onset of liver dysfunction: Post-hoc analysis of an all-case post-marketing surveillance study of iguratimod
2019 ◽
Vol 30
(4)
◽
pp. 626-632
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):